Authorize settlements with the Six (6) Remnant Defendants’ (Associated Pharmacies, Inc. [including American Associate...
Official Roll-Call Vote
Staff Report & Agenda Item Details
2026-0578 Authorize settlements with the Six (6) Remnant Defendants’ (Associated Pharmacies, Inc. [including American Associated Pharmacies]; J M Smith Corporation; Louisiana Wholesale Drug Company, Inc; Morris and Dickson Co., L.L.C; North Carolina Mutual Wholesale Drug Company, Inc; United Natural Foods) in the matter styled County of Dallas v. Purdue Pharma, et al., MDL Pretrial Cause No. 2018- 77098, in the 152nd District Court of Harris County, Texas; In re Texas Opioid Litigation, Master File Cause No. 2018-63587, in the 152nd District Court of Harris County, Texas On a motion made by Commissioner Andrew Sommerman, and seconded by Commissioner Dr. Theresa Daniel, the following order was passed and adopted by the Commissioners Court of Dallas County, State of Texas: BRIEFING DATE: May 5, 2026 FUNDING SOURCE: N/A Be it resolved and ordered that the Dallas County Commissioners Court does hereby approve the settlement of its claims against the Six (6) Remnant Defendants, Associated Pharmacies, Inc. [including American Associated Pharmacies]; J M Smith Corporation; Louisiana Wholesale Drug Company, Inc; Morris and Dickson Co., L.L.C; North Carolina Mutual Wholesale Drug Company, Inc; United Natural Foods (collectively referred to as the “Six (6) Remnant defendants”) in the matter styled County of Dallas v. Purdue Pharma, et al ., MDL Pretrial Cause No. 2018- 77098, in the 152nd District Court of Harris County, Texas; In re Texas Opioid Litigation , Master File Cause No. 2018-63587, in the 152nd District Court of Harris County, Texas (the “Lawsuit”). WHEREAS, Dallas County obtained information indicating that certain drug companies and their corporate affiliates, parents, subsidiaries, and such other defendants as may be added to the litigation (collectively, "Defendants") have engaged in fraudulent and/or reckless manufacturing, marketing, promotions, sale, and/or distribution of opioids that have resulted in addictions and overdoses; and WHEREAS, these actions, conduct and misconduct have resulted in significant financial costs in the past to the County and will undoubtedly result in significant financial costs in the future; and